Announcing a new Meetup for BioBeers!
What: CO Life Science Industry Night | Boulder 4Q10
When: Thursday, December 9th,[masked]:00 PM
Where: Atlas Building (Main Lobby)
University Colorado, Boulder
Boulder, CO 80305
Part I - CO BioInnovator Roundtables
Literal roundtables (okay, at times they may be square or rectangular) guided by CO BioInnovators leading informal and interactive discussions about new products, ideas, technologies, diseases, regulatory topics, companies, etc. Expect several CO BioInnovator Roundtables per event that are open for 60 min. Stop by a single table or make the rounds and participate in all of the diverse conversations, eavesdrop or actively engage in the dialogue, the choice is yours all the while enjoying refreshments and light snacks! See the schedule below for the exciting line-up for CO BioInnovator Roundtables. Interested in hosting a CO BioInnovator Roundtable for 4Q10 on your area of expertise?…please let us know!
Part II - CO New Biotech Meetup
Following CO BioInnovator Roundtables the party moves from the lobby to the adjacent auditorium for the formal “Meetup” portion of the program where 5 minute presentations followed by 15 minutes of Q&A are presented by life science leaders. See the schedule below for the exciting line-up for the CO New Biotech Meetup. Interested in presenting in 2011 for CO New Biotech Meetup…please let us know!
Part III - CO BioBeers
And finally, let us not forget the old standby, CO BioBeers. Following The Colorado New Biotech Meetup adjourn back to the lobby for unbridled networking, elbow-rubbing, meeting and greeting; and have a beer on the house courtesy of our friends at Twisted Pine Brewerey while Catching-up with old friends and colleagues and making new connections too.
6:00 - 7:00 CO BioInnovator Roundtables
BioInnovator Tables | To Be Announced
7:00 - 8:00 CO New Biotech Meetup (please note that doors will be closed for the start of the CO New Biotech Meetup promptly at 7:00pm)
Presentation 1 | "Flashback Technologies: Developing the Next Generation of Patient Monitoring Systems and Real-Time Predictive Medicine"
by Tim Prodanovich, COO and Director of Flashback Technologies
Presentation 2 | "Fostering Colorado Life Science: Building Sustainable Local Startup Lab Space"
by Holli Baumunk, CEO and President of The Colorado Bioscience Association
Presentation 3 | "Clarimedix: A New Device and Therapeutic Class for Neurodegenerative Disease"
by Dr. Lauren Costantini, PhD, VP of Medical and Clinical Affairs, Consultant, for Clarimedix
8:00 - 9:30 CO BioBeers
Come enjoy food and beer from Twisted Pine on the house thanks to our sponsors.
ATLAS Building (University Colorado, Boulder). Parking is available one-half block away at the University Memorial Center Parking lot.
Again, please note that doors will be closed for the start of the CO New Biotech Meetup promptly at 7:00pm.
Be certain to RSVP ASAP at http://BioBeers.com... Please help us grow our nurturing and supportive life science ecosystem by sharing this invitation with friends and colleagues! Many thanks for your interest and participation.
Tim Prodanovich, COO and Director of Flashback Technologies
Tim has over 25 years of business management experience in technology companies including VP roles at Tyco/Sensormatic, PAR Technology, Nexxion, and most recently as President of Resurgent Health and Medical. Tim has had responsibilities in the functional areas of Operations, Marketing, Sales, Customer Engineering, Finance, Business Development, and General Management. His experience includes three start-up companies as well as companies with revenues of well over $1Billion.
Holli Baumunk, CEO and President of The Colorado Bioscience Association
Holli was the Vice President of the Metro Denver Economic Development Corporation for the past seven years, prior to being named President & CEO of the Colorado BioScience Association (CBSA) July 12. An accomplished economic development executive, Baumunk was chosen last year as Colorado's Economic Developer of the Year by the Economic Development Council of Colorado, and is well known to many in the Colorado Bioscience Industry, having worked closely with the CBSA on numerous initiatives over the years. A top priority of her first year will be working on creating a “fund of funds,” designed to supply capital to private venture funds investing in startup companies that commercialize Colorado technologies in the biotech drug, medical device, biofuel and clean technology fields. An industry road map prepared for the CBSA in 2008 recommended pushing for a $250 million “fund of funds” similar to ones in other states that use money from state employee pension funds and other investors.
Dr. Lauren Costantini, PhD, Consultant, VP of Medical and Clinical Affairs of Clarimedix
Lauren has over 15 years of experience in pharmaceutical development and is a recognized leader in the area of central nervous system (CNS). Dr. Costantini was most recently Vice President, Research and Development at Sierra Neuropharmaceuticals, focusing on intracerebral delivery of medications for epilepsy. Prior to joining Sierra, she was Vice President of Clinical Development at Accera, Inc. where she directed the Clinical and Regulatory departments through clinical trials and commercialization of an Alzheimer’s disease product. Prior to Accera, Dr. Costantini directed Product Development at Titan Pharmaceuticals, Inc., developing novel treatments for CNS disorders including drug delivery, gene therapy and cell therapy platforms for Parkinson’s and Huntington’s disease, opioid dependency, chronic pain, stroke, schizophrenia, smoking cessation, and diabetes.
Previously, Dr. Costantini was on faculty at Harvard Medical School where she investigated mechanisms and treatments for neurodegeneration. Dr. Costantini serves on review boards for several journals and grant foundations including the Michael J. Fox Foundation for Parkinson’s.